Polaris News

POLARISqb and Scientist.com Partner to Offer Online Access to Quantum-Aided Drug Design, the first Quantum-Enabled Drug Discovery Platform
POLARISqb, the first company to build quantum-enabled molecular optimization tools for  drug discovery, and Scientist.com, the life science industry's leading online marketplace for outsourced research, have partnered to offer researchers online access to POLARISqb’s Quantum-Aided Drug Design (QuADD) platform. Scientist.com marketplace users can now utilize quantum computing to create optimized molecular libraries for drug design…
Read more
Quantum-Aided Drug Design from POLARISqb Demonstrates Best-in-Class Capabilities
Polaris Quantum Biotech (POLARISqb), the leader in quantum computing-based drug design, announced the development of Quantum-Aided Drug Design (QuADD) for molecular library optimization in April 2023. QuADD runs on  quantum computers that solve problems with unprecedented speed and power, allowing users to search a chemical space of more than 1030 molecules for those that complement…
Read more
POLARISqb Receives DARPA IMPAQT Funding to Advance Quantum Computing for Drug Design
The Defense Advanced Research Project Agency (DARPA) awarded POLARISqb a research contract in support of their work designing drugs with quantum computers. The contract is a part of the Advanced Research Concept topic Imagining Practical Applications for a Quantum Tomorrow (IMPAQT). POLARISqb has been developing quantum computing methods for drug discovery since their inception in…
Read more